Fiocruz and GEMMABio Partner for Gene Therapy Development

Oct 18, 2024•about 1 year ago

Contract Type

partnership

BiotechnologyHealth Care

Description

Fiocruz and GEMMABio have announced a partnership aimed at advancing the development of gene therapies. This collaboration brings together Fiocruz's expertise in research and GEMMABio's focus on biotechnology to drive innovation in the field of gene therapy.

Company Information

Company

Fiocruz and GEMMABio

About

Fiocruz is a research institution affiliated with the Brazilian Ministry of Health. GEMMABio is a biotechnology company specializing in gene therapies.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months